Published in PLoS One on May 21, 2009
Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. J Virol (2009) 1.49
Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon. J Virol (2011) 1.16
Foot-and-mouth disease virus exhibits an altered tropism in the presence of specific immunoglobulins, enabling productive infection and killing of dendritic cells. J Virol (2010) 0.85
Out-of-sequence signal 3 as a mechanism for virus-induced immune suppression of CD8 T cell responses. PLoS Pathog (2014) 0.84
Inoculation of swine with foot-and-mouth disease SAP-mutant virus induces early protection against disease. J Virol (2011) 0.84
A replication analysis of foot-and-mouth disease virus in swine lymphoid tissue might indicate a putative carrier stage in pigs. Vet Res (2011) 0.81
Cattle remain immunocompetent during the acute phase of foot-and-mouth disease virus infection. Vet Res (2011) 0.79
The Pathogenesis of Foot-and-Mouth Disease in Pigs. Front Vet Sci (2016) 0.79
Interleukin-10 production at the early stage of infection with foot-and-mouth disease virus related to the likelihood of persistent infection in cattle. Vet Res (2015) 0.78
Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle. Clin Vaccine Immunol (2015) 0.77
Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity. J Gen Virol (2014) 0.76
IL-10: A Multifunctional Cytokine in Viral Infections. J Immunol Res (2017) 0.75
Effect of Foot-and-Mouth Disease Virus Infection on the Frequency, Phenotype and Function of Circulating Dendritic Cells in Cattle. PLoS One (2016) 0.75
Systemic immune response and virus persistence after foot-and-mouth disease virus infection of naïve cattle and cattle vaccinated with a homologous adenovirus-vectored vaccine. BMC Vet Res (2016) 0.75
Immune response and viral persistence in Indian buffaloes (Bubalus bubalis) infected with foot-and-mouth disease virus serotype Asia 1. Clin Vaccine Immunol (2009) 0.75
Immunobiology of dendritic cells. Annu Rev Immunol (2000) 23.65
The dendritic cell system and its role in immunogenicity. Annu Rev Immunol (1991) 23.09
Toll-like receptor control of the adaptive immune responses. Nat Immunol (2004) 19.15
Interleukin-10. Annu Rev Immunol (1993) 10.14
Interleukin-10 determines viral clearance or persistence in vivo. Nat Med (2006) 8.01
Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature (1997) 5.80
Interleukin-10 and related cytokines and receptors. Annu Rev Immunol (2004) 5.41
Systematic nomenclature of picornavirus proteins. J Virol (1984) 5.26
Developmental regulation of MHC class II transport in mouse dendritic cells. Nature (1997) 5.17
Dendritic cells in a mature age. Nat Rev Immunol (2006) 5.03
Foot-and-mouth disease. Clin Microbiol Rev (2004) 4.34
The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med (2004) 3.59
Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J Exp Med (2000) 3.50
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med (1996) 3.30
Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology (1983) 3.04
To kill or be killed: viral evasion of apoptosis. Nat Immunol (2002) 3.04
Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med (1997) 2.90
Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat Immunol (2001) 2.77
Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol (2001) 2.39
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc Natl Acad Sci U S A (2004) 2.38
Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr Top Microbiol Immunol (2002) 2.32
Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity. J Virol (2000) 2.26
Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J Virol (2000) 2.24
HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc Natl Acad Sci U S A (2001) 2.14
Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion. J Clin Invest (2004) 2.11
Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J Exp Med (2005) 2.10
Viral interference with antigen presentation. Nat Immunol (2002) 2.05
Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology (2006) 2.03
Deliberate removal of T cell help improves virus-neutralizing antibody production. Nat Immunol (2004) 1.90
Coevolution of cells and viruses in a persistent infection of foot-and-mouth disease virus in cell culture. J Virol (1988) 1.90
Viral evasion of natural killer cells. Nat Immunol (2002) 1.74
Foot-and-mouth disease virus: a long known virus, but a current threat. Vet Res (2001) 1.70
Evolutionary transition toward defective RNAs that are infectious by complementation. J Virol (2004) 1.61
Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur J Immunol (2003) 1.60
Immunosuppression in viral infections. Rev Infect Dis (1987) 1.55
Viruses can cause disease in the absence of morphological evidence of cell injury: implication for uncovering new diseases in the future. J Infect Dis (1989) 1.28
Preextinction viral RNA can interfere with infectivity. J Virol (2004) 1.26
Bone marrow-derived dendritic cells, infection with human immunodeficiency virus, and immunopathology. Annu Rev Immunol (1997) 1.17
Modulation of the anti-inflammatory interleukin 10 and of proapoptotic IL-18 in patients with chronic hepatitis C treated with interferon alpha and ribavirin. J Viral Hepat (2006) 1.12
Plasmacytoid dendritic cell activation by foot-and-mouth disease virus requires immune complexes. Eur J Immunol (2006) 1.10
Anatomy of viral persistence: mechanisms of persistence and associated disease. Adv Virus Res (1996) 1.07
Induction of lymphopenia and inhibition of T cell function during acute infection of swine with foot and mouth disease virus (FMDV). Vet Immunol Immunopathol (2003) 1.06
T cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model. J Gen Virol (1989) 1.01
Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen. FEMS Immunol Med Microbiol (2008) 1.01
HIV-1 induces IL-10 production in human monocytes via a CD4-independent pathway. Int Immunol (2005) 1.00
Human cytomegalovirus disrupts constitutive MHC class II expression. J Immunol (2002) 0.99
Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine. J Virol (2006) 0.96
Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus. J Virol (2005) 0.95
Heterotypic recognition of recombinant FMDV proteins by bovine T-cells: the polymerase (P3Dpol) as an immunodominant T-cell immunogen. Virus Res (1998) 0.95
Impairment of thymus-dependent responses by murine dendritic cells infected with foot-and-mouth disease virus. J Immunol (2005) 0.93
Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle. Immunology (1992) 0.88
Dendritic cell internalization of foot-and-mouth disease virus: influence of heparan sulfate binding on virus uptake and induction of the immune response. J Virol (2008) 0.88
Cure of chronic viral infection and virus-induced type 1 diabetes by neutralizing antibodies. Clin Dev Immunol (2006) 0.85
The early protective thymus-independent antibody response to foot-and-mouth disease virus is mediated by splenic CD9+ B lymphocytes. J Virol (2007) 0.85
A Trypanosoma cruzi antigen signals CD11b+ cells to secrete cytokines that promote polyclonal B cell proliferation and differentiation into antibody-secreting cells. Eur J Immunol (2006) 0.84
Induction of effective cross-reactive immunity by FMDV peptides is critically dependent upon specific MHC-peptide-T cell interactions. Immunology (1994) 0.83
Use of alternative receptors different than alpha-dystroglycan by selected isolates of lymphocytic choriomeningitis virus. Virology (2004) 1.11
Establishment of a bluetongue virus infection model in mice that are deficient in the alpha/beta interferon receptor. PLoS One (2009) 1.08
Hidden virulence determinants in a viral quasispecies in vivo. J Virol (2008) 1.06
Ribavirin can be mutagenic for arenaviruses. J Virol (2011) 1.03
Arenavirus genetic diversity and its biological implications. Infect Genet Evol (2009) 1.03
Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(-/-) mice against lethal bluetongue infection. Vaccine (2009) 0.97
Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine. J Virol (2006) 0.96
Foot-and-mouth disease virus (FMDV) causes an acute disease that can be lethal for adult laboratory mice. Virology (2005) 0.87
T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep. Vaccine (2011) 0.83
A replication analysis of foot-and-mouth disease virus in swine lymphoid tissue might indicate a putative carrier stage in pigs. Vet Res (2011) 0.81
New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccines. PLoS One (2010) 0.79
Distribution of the cellular prion protein (PrPC) in brains of livestock and domesticated species. Acta Neuropathol (2006) 0.79
Interleukin 8 and CK-6 chemokines specifically attract rainbow trout (Oncorhynchus mykiss) RTS11 monocyte-macrophage cells and have variable effects on their immune functions. Dev Comp Immunol (2008) 0.78
Type I interferon limits the capacity of bluetongue virus to infect hematopoietic precursors and dendritic cells in vitro and in vivo. J Virol (2013) 0.77
Mutagenesis-mediated decrease of pathogenicity as a feature of the mutant spectrum of a viral population. PLoS One (2012) 0.77